New York Markets After Hours

McKesson upped at UBS, strong outlook for 2006

AudeLagorce

LONDON (MarketWatch) -- UBS raised its rating on McKesson Corp.
MCK, +0.24%
to "buy" from "neutral," citing a stronger pipeline in generics and an uptick in volumes due to the drug benefit bill. The broker told clients that while it was bullish on the outlook for calendar 2006, it acknowledges that 2005 will likely continue to be volatile, as market growth and price inflation tends evolve. UBS said it recommends investors to use these opportunities in 2005 to build their position in the company ahead of an expected stronger 2006.

Intraday Data provided by SIX Financial Information and subject to terms of use.
Historical and current end-of-day data provided by SIX Financial Information.
All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only.
Intraday data delayed at least 15 minutes or per exchange requirements.